Koffei

CVE-2026-6715

🟠 Medium

IBM Concert. CVE-2026-6715 and CVE-2026-15266 are two separate command-injection flaws in the same product, with the same 9.8, the same CWE-78, the same affected range and the same fixed release, disclosed in different advisories on the same day · Concert 1.0 through 3.0.1.1

CVSS (Koffei note)
9.8
CVSS (v3.1, CVE List)
9.8
EPSS (2026-11-18)
0.860%
59.21th percentile

Exploitation

No — no exploitation reported. The record has no CISA-ADP container, so there is no SSVC decision and no KEV entry to read ; CISA has not triaged it. Neither CISA KEV nor its JSON feed could be reached in this run, so KEV status comes from the record's CISA-ADP container. Existing PoC (not opened), recorded from the proof-of-concept list supplied on 09/11/2026. Rated 🟠 on the public proof of concept and on an unauthenticated 9.8 with no exploitation signal, which is the unconfirmed-high case. All five IBM ids in this batch were published on 08/11/2026, none has a CISA-ADP container yet, and none has an EPSS score, so for every one of them the CNA's own score is the only severity signal available.

Timeline

  1. 08/11/2026CVE record published (CVE List)

Risk

9.8 Critical (v3.1, IBM CNA) — AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H, No EPSS score exists yet: the id was published 08/11/2026 and is absent from the 08/11/2026 dataset, so this row counts as un-enriched until EPSS catches up. No ADP score and no ADP container at all (CWE-78 OS command injection: crafted input is incorporated into an OS command, so a remote unauthenticated attacker runs arbitrary commands with the privileges of the affected service)

Fix

Yes — IBM Concert 3.1.0

Official description

IBM Concert 1.0 through 3.0.1.1 allows an attacker can supply crafted input that is incorporated into an operating system command without adequate validation or sanitization. Successful exploitation allows remote attackers to execute arbitrary commands on the underlying operating system with the privileges of the affected service.

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

CWE-78